Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001574
Filing Date
2025-01-16
Accepted
2025-01-16 18:06:19
Documents
1
Period of Report
2025-01-15

Document Format Files

Seq Description Document Type Size
1 form4-01162025_110115.html 4  
1 form4-01162025_110115.xml 4 3691
  Complete submission text file 0001415889-25-001574.txt   5386
Mailing Address 17-17 ROUTE 208 N FAIRLAWN NJ 07410
Business Address
LEPORE PATRICK G (Reporting) CIK: 0001055404 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 25536598

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)